Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia
Open Access
- 1 February 1999
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 104 (2), 266-270
- https://doi.org/10.1046/j.1365-2141.1999.01190.x
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Pharmacogenetics and blood dyscrasiasEuropean Journal of Haematology, 1996
- When should the clinician suspect a drug‐induced blood dyscrasia, and how should he proceed?European Journal of Haematology, 1996
- Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.Environmental Health Perspectives, 1994
- Aplastic anaemia following exposure to 3,4‐methylenedioxymethamphetamine (‘Ecstasy’)British Journal of Haematology, 1994
- Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotypeHuman Molecular Genetics, 1994
- Aplastic anaemia and remoxiprideThe Lancet, 1993
- 5-nucleotidase and azathioprine-related bone-marrow toxicityThe Lancet, 1993
- Genetic polymorphism of cytochrome P4502E1 in a Swedish populationFEBS Letters, 1993
- The drug interaction potential of ranitidine: An updatePharmacology & Therapeutics, 1991
- Identification of the primary gene defect at the cytochrome P450 CYP2D locusNature, 1990